FINANCIAL NEWS
ASX Winners And Losers Of Today – 29-10-24
The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day
Oct 29 2024
ResMed’s Bounce-Back Complete
A stellar first quarter has underscored ResMed’s share price bounce-back from last year’s obesity drug panic, and perhaps put to bed the initial fear of GLP-1s
Oct 29 2024
Weekly Update On LICs & LITs – 29-Oct-2024
Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX
Oct 29 2024
Uranium Week: US$94lb Spot In Reach?
Spot market participants are awaiting the International Uranium Fuel Seminar, but macro continues to underpin robust investment requirements for nuclear power projects
Oct 29 2024
ANZ Bank Shares Look Poised
Michael Gable of Fairmont Equities suggests it’s but a matter of time before ANZ Bank shares break through resistance
Oct 29 2024
Bell Potter rates DRO as Upgrade to Buy from Hold
Bell Potter explains DroneShield reported a disappointing 3Q2024 investor update, which failed to meet elevated market expectations.
The company's Sept quarter revenues of $31.1m fell -20% on the previous year, but Q32023 included a one-off $33m contract.
Assessing management's 2024 contracted revenue guidance, the broker downgrades full year revenue estimates by -20% with less material downgrades for 2025/2026.
Bell Potter lowers EPS estimates by -57% and -28% for 2024/2025.
At current share price levels, the analyst believes this is an attractive entry point and upgrades DroneShield to a Buy from Hold.
Target price is lowered to $1.20 as a result of the earnings forecast changes.
Shaw and Partners rates PDN as Buy, High Risk
Commissioning issues at the Langer Heinrich mine in Namibia resulted in a "disappointing" 1Q for Paladin Energy, according to Shaw and Partners. It's felt they were standard commissioning issues, and a -15% share price reaction was overdone.
The Buy, High Risk rating is maintained, and Paladin remains Shaw and Partners preferred exposure to the uranium sector
The broker's target falls to $16.00 from $16.80 after an -11% cut to the FY25 EBITDA forecast due to lower assumed production.
Citi rates ZIP as Downgrade to Neutral from Buy
Updates by Citi on today's 1Q result for Zip Co will follow, but new research by the broker early today involved a preview of the now-released result.
The broker raises its target to $2.90 from $1.90 and downgrades to Neutral from Buy on valuation.
On cue, the analysts updated for the result around midday, highlighting US growth continues to surprise on the upside.
In an early assessment, Citi anticipates consensus will need to upgrade total transaction value (TTV), revenue and cash EBTDA forecasts given the ongoing momentum in the US and a strong net transaction margin (NTM) in A&NZ.
US total transaction value (TTV) beat Citi's forecast by 5% after rising to 43% year-on-year from 42%. Also, revenue yield in the US increased to 7.1%, reflecting higher usage of the Zip app, in the broker's view.
Considering Zip Plus has not been actively promoted as yet (and is higher yielding), Citi is impressed by a 19.2% increase in revenue yield.
In a further positive, funding costs continue to fall, with the weighted average margin of 2.13% on the latest note issuance, down from 2.65% previously.
Target $2.90 and Neutral.
Click here to see full report
ANALYSIS & DATA
FNARENA'S MARKET CONSENSUS FORECASTS
To display the stock analysis for a company please enter the company code:
ANZ | ANZ GROUP HOLDINGS LIMITED
Abbreviated format - see the full version here
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$31.45 28 Oct |
-0.260 OPEN $31.71 |
-0.82% HIGH $31.71 |
1,687,727 LOW $31.35 |
TARGET | |||
$27.435 -12.8% downside | |||
Franking for last dividend paid out: 65% |
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 236.8 | 226.3 | xxx |
DPS (cps) | xxx | 175.0 | 164.8 | xxx |
EPS Growth | xxx | - 5.3% | - 4.5% | xxx |
DPS Growth | xxx | 20.3% | - 5.8% | xxx |
PE Ratio | xxx | N/A | 13.9 | xxx |
Dividend Yield | xxx | N/A | 5.2% | xxx |
Div Pay Ratio(%) | xxx | 73.9% | 72.8% | xxx |
DAILY FINANCIAL NEWS
ResMed’s Bounce-Back Complete
A stellar first quarter has underscored ResMed’s share price bounce-back from last year’s obesity drug panic, and perhaps put to bed the initial fear of GLP-1s
Oct 29 2024 - Australia
Michael Gable of Fairmont Equities suggests it’s but a matter of time before ANZ Bank shares break through resistance
Oct 29 2024 - Technicals
Brambles posted weaker than expected first quarter sales, but a number of impacting factors leave analysts confident FY25 guidance will be met as conditions improve
Oct 29 2024 - Australia
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
Oct 26 2024 - Australia
Nick Scali’s gross margins have been impacted by materially higher than expected freight rates, but such headwinds should not feature permanently
Oct 24 2024 - Small Caps
Edited extract from Virgin Millionaire: The step-by-step guide to your first million and beyond by Ben Nash
Oct 23 2024 - Book Reviews
PR NEWSWIRE
Hakluyt announces new partnership with the Clontarf Foundation
3:00 AM - PR NewsWire
Traveloka and LOTTE HOTELS AND RESORTS Partners to Invite 50 Million Travellers from SEA and Australia to Explore South Korea
12:22 AM - PR NewsWire
Arctech Showcases Advanced Solar Tracking Solutions and Energy Storage Systems at All Energy Australia 2024
Oct 29 2024 - PR NewsWire
CG FinTech Forges Game-Changing Alliance with Adelaide United as Official Trading Partner
Oct 29 2024 - PR NewsWire
NEXTGEN launches Connect to Empower Technology Start-Ups and ISV Vendors in Australia and New Zealand.
Oct 29 2024 - PR NewsWire
TOPBAND at All Energy AU 2024 Leads in Sustainable Storage Innovations
Oct 29 2024 - PR NewsWire
RUDI'S VIEWS
Rudi’s View: Earnings, Best Ideas & Favourite Stock Picks
Updates on stock picker’s favourites and Model Portfolio adjustments
Oct 24 2024
DAILY MARKET REPORTS
ASX Winners And Losers Of Today – 29-10-24
The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day
Oct 29 2024
The Overnight Report: Trump, Bonds & Value
A global perspective on what happened overnight
Oct 29 2024
Today’s Financial Calendar – 29-10-2024
Significant Scheduled Events For 29 October, 2024
Oct 29 2024
ASX Winners And Losers Of Today – 28-10-24
The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day
Oct 28 2024
Australian Broker Call *Extra* Edition – Oct 28, 2024
Extra Edition of the Broker Call Report
Oct 28 2024
The Monday Report – 28 October 2024
Wrap of events affecting the market on Friday night and the weekend and a preview of the week ahead
Oct 28 2024
Today’s Financial Calendar – 28-10-2024
Significant Scheduled Events For 28 October, 2024
Oct 28 2024
WEEKLY REPORTS
Weekly Update On LICs & LITs – 29-Oct-2024
Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX
Oct 29 2024
Uranium Week: US$94lb Spot In Reach?
Spot market participants are awaiting the International Uranium Fuel Seminar, but macro continues to underpin robust investment requirements for nuclear power projects
Oct 29 2024
Australian Listed Real Estate Tables – 28-10-2024
FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data
Oct 28 2024
Weekly Ratings, Targets, Forecast Changes – 25-10-24
Weekly update on stockbroker recommendation, target price, and earnings forecast changes
Oct 28 2024
Next Week At A Glance – 28 Oct -1 Nov 2024
A brief look at important company events and economic data releases next week
Oct 25 2024
In Case You Missed It – BC Extra Upgrades & Downgrades – 25-10-24
A summary of the highlights from Broker Call Extra updates throughout the week past
Oct 25 2024
Weekly Top Ten News Stories – 25 October 2024
Our top ten news stories from 17 October 2024 to 24 October 2024
Oct 25 2024
In Brief: Aurum, Hillgrove & Little Green Pharma
Weekly Broker Wrap: Under-appreciated and unknown gold/copper plays with a touch of cannabis cash flow.
Oct 25 2024
The Short Report – 24 Oct 2024
FNArena’s weekly update on short positions in the Australian share market
Oct 24 2024
THE MARKETS
Click item/line to change chart
FNARENA WINDOWS
Window on MEDICAL EQUIPMENT & DEVICES
ResMed’s Bounce-Back Complete
A stellar first quarter has underscored ResMed’s share price bounce-back from last year’s obesity drug panic, and perhaps put to bed the initial fear of GLP-1s
Oct 29 2024
Window on WEALTH MANAGEMENT & INVESTMENTS
Weekly Update On LICs & LITs – 29-Oct-2024
Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX
Oct 29 2024
Window on URANIUM
Uranium Week: US$94lb Spot In Reach?
Spot market participants are awaiting the International Uranium Fuel Seminar, but macro continues to underpin robust investment requirements for nuclear power projects
Oct 29 2024
GEN AI
Dicker Data Preps For PC Refresh Cycle Upswing
Analysts see value in Dicker Data shares based on second quarter momentum and potential upside to PC sales
Sep 17 2024